Cole Pinnow
Chief Commercial Officer · Cogent Biosciences, Inc.
Individual
- 2025
- Dec 19, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cole Pinnow files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- John Edward Robinson - $3.49M in COGT purchases and sales in the last 12 months
- Jessica Sachs - $3.20M in COGT purchases and sales in the last 12 months
- John L. Green - $2.98M in COGT purchases and sales in the last 12 months
- Evan Kearns - $2.52M in COGT purchases and sales in the last 12 months
- Arlene Morris - $1.69M in COGT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cole Pinnow?
Cole Pinnow is a corporate insider, tracked as Chief Commercial Officer of Cogent Biosciences, Inc. (COGT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Cole Pinnow last file a Form 4?
The only primary Form 4 on record is dated 19 December 2025.
